SHARE CAPITAL

6 Months Ended

Jul. 30, 2022

SHARE CAPITAL

4. SHARE CAPITAL

Authorized

An unlimited number of common shares.

Issued and outstanding

	July 30,		January 29,
	2022		2022
	$		$
Share Capital - (26,561,744) Common shares (January 29, 2022 - 26,423,717)		113,862		113,534

During the three and six-month periods ended July 30, 2022, 134,452 and 138,027 common shares, respectively, (July 31, 2021 – 104,200 and 125,387 common shares, respectively), were issued in relation to the vesting of restricted stock units (“RSU”), resulting in an increase in share capital of $322 and $328, net of tax (July 31, 2021 – $70 and $239, net of tax respectively) and a reduction in contributed surplus of $658 and $670 respectively (July 31, 2021 – $142 and $486, respectively).

Stock-based compensation

As at July 30, 2022, 694,412 (July 31, 2021, 937,868) common shares remain available for issuance under the 2015 Omnibus Plan.

No stock options were granted during the three and six-month periods ended July 30, 2022 and July 31, 2021. A summary of the status of the Company’s stock option plan during the six-month periods is presented below.

	For the six-months ended
	July 30,				July 31,
	2022				2021
			Weighted				Weighted
			average				average
	Options		exercise		Options		exercise
	outstanding		price		outstanding		price
	#		$		#		$
Outstanding and exercisable - beginning and end of period		3,490		14.39		17,490		6.32

A summary of the status of the Company’s RSU plan and changes during the six-month periods are presented below.

	For the six-months ended
	July 30,					July 31,
	2022					2021
				Weighted					Weighted
				average					average
	RSUs			fair value		RSUs			fair value
	outstanding			per unit (1)		outstanding			per unit (1)
	#			$		#			$
Outstanding, beginning of period		1,282,790			2.60		1,306,101			1.70
Granted		511,264			2.66		425,764			4.64
Forfeitures		(27,466	)		2.28		(32,747	)		1.50
Vested		(138,027	)		2.38		(125,387	)		1.91
Vested, withheld for tax		(143,711	)		2.38		(130,562	)		1.91
Outstanding, end of period		1,484,850			2.67		1,443,169			2.53

_____________

(1) Weighted average fair value per unit as at date of grant.

During the three and six-month periods ended July 30, 2022, the Company recognized a stock-based compensation expense of $398 and $708, respectively (July 31, 2021 – $363 and $545, respectively).